Elkem (ELK) EGM 2026 summary
Event summary combining transcript, slides, and related documents.
EGM 2026 summary
9 Mar, 2026Opening remarks and agenda
Deputy chairman welcomed participants and provided practical information about the virtual meeting format and voting procedures.
Attendance included key executives and legal counsel, with a detailed breakdown of shares represented.
Specific resolutions to be voted on
Election of Hans Cappelen Arnesen as chair and Morten Viga as co-signer of the minutes was proposed and approved.
Approval of the notice and agenda for the meeting was proposed and passed.
Approval of a share purchase agreement with Bluestar was proposed and adopted.
Proposal for a share capital decrease related to the share purchase agreement was presented and approved.
Overview of voting outcomes
489,624,551 shares, representing 77.2% of share capital, participated in voting.
All proposed resolutions, including the share purchase agreement and share capital decrease, were approved.
Bluestar was excluded from voting on the share purchase agreement.
Latest events from Elkem
- Cost reductions, equity raise, and refinancing strengthen financials amid ongoing market headwinds.ELK
Q2 2026 - EBITDA fell 65% year-over-year as transformation, cost cuts, and refinancing reshape the business.ELK
Q1 2026 - Portfolio reshaping and cost cuts position the company for focused growth amid market challenges.ELK
DNB Carnegie Small & Medium Enterprises Conference presentation - Silicones division sale drives transformation, cost cuts, and growth focus amid challenging markets.ELK
JP Morgan European Chemicals Forum presentation - Silicones division sale to Bluestar and weak Q4 2025 results mark a major transformation.ELK
Q4 2025 - Strong financial performance and strategic investments drive sustainable growth.ELK
SEB Nordic Seminar presentation - 2024 saw strong financials, strategic portfolio review, and top-tier ESG achievements.ELK
DNB Small & Medium Enterprises Conference presentation - EBITDA hit NOK 1,235 million, up 131% year-over-year, driven by Silicones and cost programs.ELK
Q3 2024 - EBITDA stable at NOK 1,030m; net profit up on tax assets, Silicones improved despite weak demand.ELK
Q2 2024